SCOPE of Pain: Safe and Competent Opioid Prescribing Education, Boston University

What is the SCOPE of Pain?

SCOPE of Pain is a series of continuing medical education/continuing nursing education activities designed to help you safely and effectively manage patients with chronic pain, when appropriate, with opioid analgesics. Our program consists of:

  • A 3-module cased-based online activity; and
  • Live conferences held around the US

Live conferences Online training

Trainer's Toolkit

A resource to facilitate safe opioid prescribing training of physicians, NPs, PAs, nurses and other clinicians in your institution or practice.

Access the toolkit

Additional Opioid Prescribing Education

After you have attended one of the SCOPE of Pain live meetings or completed the SCOPE of Pain online program, we suggest that you visit This online program provides in-depth training that focuses on effective communication skills as well as the potential risks and benefits of opioids and when and how to initiate, maintain, modify, continue or discontinue opioid therapy.


Earn Part II Self-Assessment MOC Credits

Scope of Pain has been approved as a Part II Self-Assessment Activity by the following ABMS Member boards:

National Recognition for the SCOPE of Pain Program

2014 National High Intensity Drug Trafficking Area (HIDTA) Award
The White House Office of National Drug Control Policy Director Michael Botticelli has awarded Boston University School of Medicine's Safe and Competent Opioid Prescribing Education (SCOPE of Pain) program a 2014 National High Intensity Drug Trafficking Area (HIDTA) award for Outstanding Prevention Effort. Read More!

Published Online August 2015 in the Journal Pain Medicine
Educating clinicians on how to safely prescribe opioids can help decrease opioid misuse among chronic pain sufferers.

These findings, which appear online in the journal Pain Medicine, confirm that education can empower clinicians to make more informed clinical decisions about initiating, continuing, changing or discontinuing opioids for patients suffering from chronic pain based on a careful benefit versus risk/harm assessment.

© 2015 Trustees of Boston University.